Eight Roads Ventures — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology.
BiotechHealthtech
Hui Li(Founder, President & CEO)in
Co-investorsF-Prime CapitalQuan CapitalDelta Capital
K36 Therapeutics develops small-molecule inhibitors targeting the histone methyltransferase NSD2 for hematologic and solid tumor cancers.
BiotechHealthtech
Co-investorsAtlas VentureF-Prime CapitalNextech Invest
SAFE Security provides an AI-driven platform for cyber risk management, covering third-party risk management (TPRM), continuous threat exposure management (CTEM), AI security posture management (AI-SPM), and cyber risk quantification (CRQ).
AI & Machine LearningCybersecurityEnterprise Software
Saket Modi(Founder & CEO)in
Co-investorsAlliance of AngelsJC2 VenturesMS&AD VenturesPaladin Capital GroupTitanium VenturesAvataar Venture Partners+5 more
Thinksurance offers a digital "Advisory Suite," an omnichannel consultation and sales platform that connects insurers, underwriting agents, and brokers to distribute insurance products across B2C and B2B channels.
FintechInsurTechSaaS
Co-investorsMTECH CAPITALColumbia Lake PartnersVIEWPOINT VENTURES
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.